非酒精性脂肪性肝病中的红细胞功能障碍：分子机制的标志物与介质
Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms.
作者信息
Papadopoulos Charalampos, Tentes Ioannis, Anagnostopoulos Konstantinos
机构信息
Laboratory of Biochemistry, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
出版信息
Maedica (Bucur). 2020 Dec;15(4):513-516. doi: 10.26574/maedica.2020.15.4.513.
Abstract
Despite efforts to unravel the pathogenetic mechanisms of non-alcoholic fatty liver disease (NAFLD), there is still a need for approved treatments and biomarkers. Interestingly, red blood cells present alterations in their characteristics during NAFLD. The phosphatidylcholine to phosphatidylethanolamine ratio, fatty acid profile, red blood cell count and red cell distribution width reflect molecular changes that are taking place in the liver. In addition, glycosylated hemoglobin, chemokine binding and release, and phosphatidylserine exposure actively participate in NAFLD pathogenesis. In this review, we describe the neglected red blood cell dysfunction in NAFLD, with the aim to unveil potent biomarkers and therapeutic targets.
摘要
尽管人们努力揭示非酒精性脂肪性肝病（NAFLD）的发病机制，但仍需要获批的治疗方法和生物标志物。有趣的是，在NAFLD期间红细胞的特征会出现改变。磷脂酰胆碱与磷脂酰乙醇胺的比例、脂肪酸谱、红细胞计数和红细胞分布宽度反映了肝脏中正在发生的分子变化。此外，糖化血红蛋白、趋化因子的结合与释放以及磷脂酰丝氨酸的暴露都积极参与了NAFLD的发病过程。在这篇综述中，我们描述了NAFLD中被忽视的红细胞功能障碍，旨在揭示有效的生物标志物和治疗靶点。
相似文献
1
Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms.非酒精性脂肪性肝病中的红细胞功能障碍：分子机制的标志物与介质
Maedica (Bucur). 2020 Dec;15(4):513-516. doi: 10.26574/maedica.2020.15.4.513.
2
High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.高红细胞分布宽度与非酒精性脂肪性肝病密切相关。
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):174-8. doi: 10.1097/MEG.0b013e328365c403.
3
Epigenetics in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的表观遗传学。
Mol Aspects Med. 2017 Apr;54:78-88. doi: 10.1016/j.mam.2016.11.008. Epub 2016 Nov 23.
4
Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).高血糖诱导人肝上皮 HepG2 细胞发生关键的基因和表型改变，与非酒精性脂肪性肝病（NAFLD）的 Leprdb/J 小鼠模型相平行。
PLoS One. 2019 Dec 5;14(12):e0225604. doi: 10.1371/journal.pone.0225604. eCollection 2019.
5
Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.血红蛋白联合甘油三酯和铁蛋白预测非酒精性脂肪肝
J Gastroenterol Hepatol. 2014;29(7):1508-14. doi: 10.1111/jgh.12580.
6
Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪肝（NAFLD）患者红细胞膜饱和度指数显著降低。
Lipids Health Dis. 2017 Aug 23;16(1):160. doi: 10.1186/s12944-017-0552-0.
7
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.非酒精性脂肪性肝病中的趋化因子配体2和对氧磷酶-1：寻找其他致病因素
World J Gastroenterol. 2015 Mar 14;21(10):2875-82. doi: 10.3748/wjg.v21.i10.2875.
8
Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.非酒精性脂肪性肝病严重程度和肥胖儿童的代谢并发症：ω-3 脂肪酸的影响。
J Nutr Biochem. 2018 Aug;58:28-36. doi: 10.1016/j.jnutbio.2018.03.025. Epub 2018 Apr 10.
9
Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease.重新审视代谢综合征并为非酒精性脂肪性肝病中的 microRNAs 铺平道路。
FEBS J. 2014 Jun;281(11):2503-24. doi: 10.1111/febs.12806. Epub 2014 Apr 28.
10
Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.血红蛋白水平升高与儿童非酒精性脂肪性肝病的晚期纤维化相关。
J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):150-155. doi: 10.1097/MPG.0000000000001614.
引用本文的文献
1
Innate Immunity Receptor TLR9 Drives Erythrocyte Cholesterol and Ferroprotin Accumulation in a Glutaminase-Independent Manner. Implications for Metabolic Associated Fatty Liver Disease.固有免疫受体TLR9以不依赖谷氨酰胺酶的方式驱动红细胞胆固醇和铁转运蛋白积累。对代谢相关脂肪性肝病的意义。
Maedica (Bucur). 2025 Jun;20(2):220-227. doi: 10.26574/maedica.2025.20.2.220.
2
Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation.肝病中的红细胞凋亡：对贫血和高凝状态的影响
Med Sci (Basel). 2025 Aug 12;13(3):125. doi: 10.3390/medsci13030125.
3
Significant Increase in Oxidative Stress Indices in Erythrocyte Membranes of Obese Patients with Metabolically-Associated Fatty Liver Disease.患有代谢相关脂肪性肝病的肥胖患者红细胞膜氧化应激指标显著升高。
J Pers Med. 2024 Mar 18;14(3):315. doi: 10.3390/jpm14030315.
4
Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α Release.非酒精性脂肪性肝病患者的红细胞条件培养基中MCP1含量增加并诱导TNF-α释放。
Rep Biochem Mol Biol. 2022 Apr;11(1):54-62. doi: 10.52547/rbmb.11.1.54.
本文引用的文献
1
Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis, before and after Treatment with Direct Antiviral Agents: A pilot Study.丙型肝炎合并严重纤维化患者在接受直接抗病毒药物治疗前后红细胞膜中胆固醇和磷脂的分布模式：一项初步研究
Maedica (Bucur). 2020 Jun;15(2):162-168. doi: 10.26574/maedica.2020.15.2.162.
2
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.非酒精性脂肪性肝病诊断和监测的无创性生物标志物研究进展。
Metabolism. 2020 Oct;111S:154259. doi: 10.1016/j.metabol.2020.154259. Epub 2020 May 5.
3
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.非酒精性和酒精性脂肪性肝病的流行病学
Transl Gastroenterol Hepatol. 2020 Apr 5;5:16. doi: 10.21037/tgh.2019.09.08. eCollection 2020.
4
HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.糖化血红蛋白即使在正常范围内也可能导致非酒精性脂肪性肝病的发生。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20193996.
5
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.非酒精性脂肪性肝病的发生和发展：晚期糖基化终产物的作用。
Int J Mol Sci. 2019 Oct 11;20(20):5037. doi: 10.3390/ijms20205037.
6
Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome.健康人群和急性呼吸窘迫综合征患者红细胞磷脂分子流的研究。
PLoS One. 2019 Aug 27;14(8):e0221595. doi: 10.1371/journal.pone.0221595. eCollection 2019.
7
The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects.血红蛋白糖化指数与健康受试者的非酒精性脂肪肝有关。
Clin Endocrinol (Oxf). 2019 Aug;91(2):271-277. doi: 10.1111/cen.14001. Epub 2019 May 10.
8
Changes of the Fatty Acid Profile in Erythrocyte Membranes of Patients following 6-Month Dietary Intervention Aimed at the Regression of Nonalcoholic Fatty Liver Disease (NAFLD).患者经过 6 个月旨在非酒精性脂肪肝（NAFLD）消退的饮食干预后，红细胞膜中脂肪酸谱的变化。
Can J Gastroenterol Hepatol. 2018 Dec 4;2018:5856201. doi: 10.1155/2018/5856201. eCollection 2018.
9
Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.糖化血红蛋白与无糖尿病的非酒精性脂肪性肝病患者发生晚期纤维化的风险相关。
Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):58-66. doi: 10.1016/j.clinre.2018.08.007. Epub 2018 Sep 28.
10
The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity.不断演变的红细胞：作为固有免疫调节剂的红血细胞。
J Immunol. 2018 Sep 1;201(5):1343-1351. doi: 10.4049/jimmunol.1800565.
Zotero 插件